It is a chemicals and materials private limited company based in Hyderabad, Telangana, India, established in 1981.
1981 | Hyderabad, Telangana, India | ActiveBactolac Pharmaceuticals Private Limited, a active private limited company, was established on 10 July 1981 in Hyderabad, Telangana, India. Engaging in specialty chemicals within the chemicals and materials sector, it holds CIN: U24230TG1981PTC003103. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.03 M.
It upholds a compliant status. Its leadership includes Desani Damoder Reddy (Managing Director), Desani Surender Reddy (Whole-Time Director). Past directors included Desani Radha, Desani Srinivas Reddy. It holds no open charges and ₹0.40 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 564-A-16/4, , Road No. 92 Jubilee Hills, Hyderabad, Telangana, 500034.
U24230TG1981PTC003103
003103
10 July 1981
₹2.50 M
₹2.03 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Bactolac Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Desani Damoder Reddy | Managing Director | 25 Jun 1992 | Current |
| Desani Surender Reddy | Whole-Time Director | 11 Feb 1993 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Jan 2009 | Past |
| Pramod Abcsdd | Director | 01 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bactolac Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 34.21% decrease. The company also saw a substantial fall in profitability, with a 191.21% decrease in profit. The company's net worth dipped by a decrease of 1.32%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Bactolac Pharmaceuticals had a promoter holding of 60.08% and a public holding of 39.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹400,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2003 | Bank Of Baroda | ₹0.40 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Bactolac Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bactolac Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bactolac Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Bactolac Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Bactolac Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
The activity A charge registered on 27 Jun 2003 via Charge ID 90263317 with Bank Of Baroda was fully satisfied on 04 May 2010. was completed.
Progress on A charge with Bank Of Baroda amounted to Rs. 0.40 M with Charge ID 90263317 was registered on 27 Jun 2003. was documented.
The activity Desani Surender Reddy was appointed as a Whole-time director was appointed as a Whole-time director on 11 Feb 1993 & has been associated with this company since 32 years 10 months . was completed.
The activity Desani Damoder Reddy was appointed as a Managing Director was appointed as a Managing Director on 25 Jun 1992 & has been associated with this company since 33 years 6 months . was completed.
The CIN of Bactolac Pharmaceuticals Private Limited is U24230TG1981PTC003103.
Bactolac Pharmaceuticals Private Limited is headquartered at Plot No. 564-A-16/4, , Road No. 92 Jubilee Hills, Hyderabad, Telangana, 500034.
Bactolac Pharmaceuticals Private Limited was incorporated on 10 July 1981.
The current directors of Bactolac Pharmaceuticals Private Limited are
The primary industry of Bactolac Pharmaceuticals Private Limited is Chemicals And Materials.
Bactolac Pharmaceuticals Private Limited is unlisted.
The authorized capital of Bactolac Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹2.03 M.
The compliance status of Bactolac Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX